(Q36035557)

11 August 2017

The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction (English)

1 reference

11 August 2017

anti-retroviral agent

0 references

9

Charles P Quesenberry

1 reference

11 August 2017

William J Towner

1

1 reference

11 August 2017

Lanfang Xu

2

1 reference

11 August 2017

Wendy A Leyden

3

1 reference

11 August 2017

Michael A Horberg

4

1 reference

11 August 2017

Chun R Chao

5

1 reference

11 August 2017

Beth Tang

6

1 reference

11 August 2017

Daniel B Klein

7

1 reference

11 August 2017

Leo B Hurley

8

1 reference

11 August 2017

Michael J Silverberg

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

Journal of Acquired Immune Deficiency Syndromes

11 August 2017

1 reference

11 August 2017

60

1 reference

11 August 2017

3

1 reference

11 August 2017

321-327

1 reference

Prevention of HIV-1 infection with early antiretroviral therapy

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Hepatitis C virus-induced hepatocarcinogenesis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Nonalcoholic fatty liver disease: an increasingly common cause of liver disease among HIV-infected persons?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Hepatic steatosis and HIV infection.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Clinical consequences of hepatitis C virus infection.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

A model to predict survival in patients with end-stage liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

AIDS across Europe, 1994-98: the EuroSIDA study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3376230

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

23 September 2018

1 reference

12 December 2020

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

1 reference

12 December 2020

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management

1 reference

12 December 2020

Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

1 reference

12 December 2020

10.1097/QAI.0B013E31824E9EF2

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22343179

1 reference